A predictive F344 rat immunotoxicology model: Cellular parameters combined with humoral response to NP-CγG and KLH

Toxicology

Volumn 194, Issue 1-2, 2003, Pages 129-145

  Smith, Holly W ^a   Winstead, Colleen J ^a   Stank, Kristen K ^a   Halstead, Bartley W ^a   Wierda, Daniel ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Azathioprine; Cyclophosphamide; Cyclosporin A; Immunotoxicity; Nitrophenyl; Rat

Indexed keywords

AZATHIOPRINE; BENZENE DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HAPTEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; KEYHOLE LIMPET HEMOCYANIN; NITROPHENYL CHICKEN GAMMA GLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ASSAY; CELLULAR PARAMETERS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; LYMPHOCYTE; MODEL; NATURAL KILLER CELL; NONHUMAN; ORGAN WEIGHT; PHENOTYPE; PRIORITY JOURNAL; RAT; SPLEEN CELL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALIA; GALLUS GALLUS;

EID: 0242712274     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2003.07.002     Document Type: Article

References (45)

1. Basketter D.A., Bremmer J.N., Buckley P., Kammuller M.E., Kawabata T., Kimber I., Loveless S.E., Magda S., Stringer D.A., Vohr H.W. Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology. Food Chem. Toxicol. 33(3):1995;239-243.
2. Berzofsky, J.A., Berkower, I.J., 1999. Immunogenicity and antigen structure. In: William, E.P. (Ed.), Fundamental Immunology, fourth ed. Lippincott-Raven, Philadelphia, PA (Chapter 19).
3. Bleavins, M.R., Iglesia, F.A., Munson, A.E., et al., 1991. Effects of CI-949, a novel antiallergy agent, on immune function of male Fischer 344 rats. J. Pharmacol. Exp. Ther. 257, 316-322.
4. CPMP (Committee for Proprietary Medicinal Products), 2000. Note for guidance on repeated dose toxicity. CPMP/SWP/1042/99.
5. Criswell K.A., Bleavins M.R., Zielinski D., Zandee J.C. Comparison of flow cytometric and manual bone marrow differentials in Wistar rats. Cytometry. 32:1998;9-17.
6. De Waal E.J., Timmerman H.H., Dortant P.M., Kranjc M.A.M., Van Loveren H. Investigation of a screening battery for immuntoxicicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds. Regul. Toxicol. Pharmacol. 21:1995;327-338.
7. Doi T., Nagai H., Tsakuda R., Suzuki T. Dose-response relationship of cytotoxicity, PFC response and histology in the spleen in rats treated with alkylating agents. Toxicology. 107:1996;47-60.
8. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics. 20:1964;482-491.
9. Fan F., Wierda D., Rozman K.K. Effects of 2,3,7,8-tetrachlorodibenzo-p- dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats. Toxicology. 106(1-3):1996;221-228.
10. FDA (Food and Drug Administration, Center for Drug Evaluation and Research), 2002. Guidance for industry, immunotoxicity evaluation of investigational new drugs. http://www.fda.gov/cder/guidance/4945fnl.pdf.
11. Fleshner M., Deak T., Nguyen K.T., Watkins L.R., Maier S. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. J. Immunol. 166:2001;3813-3819.
12. Friberg D.D., Bryant J.L., Whiteside T.L. Measurements of natural killer NK activity and NK-cell quantification. Methods. 9:1996;316-326.
13. Heyman B., Holmquist G., Borwell P., Heyman U. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies. J. Immunol. Methods. 68:1984;193-204.
14. ICICIS, 1998. Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 125, 183-201.
15. Institóris L., Siroki O., Ündeger Ü., Basaran N., Dési I. Immunotoxicological investigations in rats dosed repeatedly with combinations of cypermethrin, As(III), and Hg(II). Toxicology. 172:2002;59-67.
16. Jacob J., Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J. Exp. Med. 176:1992;679-687.
17. Jacob J., Kassir R., Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architechture and dynamics of responding cell populations. J. Exp. Med. 173:1991;1165-1175.
18. Kawabata, T.T., 1995. Enumeration of antigen-specific antibody-forming cells by the enzyme-linked immunospot (ELISPOT) assay. In: Burleson, G.R., Dean, J.H., Munson, A.E. (Eds.), Methods in Immunology, vol. 1. Wiley-Liss, New York, Chapter 8, pp. 125-135.
19. Koller L.D., Exon J.H., Moore S.A. Evaluation of ELISA for detecting in vivo chemical immunomodulation. J. Toxicol. Environ. Health. 11:1983;15-22.
20. Ladics G.S., Loveless S.E. Cell surface marker analysis of splenic lymphocyte populations of the CD rat for use in immunotoxicological studies. Toxicol. Methods. 4(2):1994;77-91.
21. Ladics G.S., Smith C., Loveless S.E., Green J.W. Phase two of an interlaboratory evaluation of the quantification of rat splenic lymphocyte subtypes using immunofluorescent staining and flow cytometry. Toxicol. Methods. 8:1998;87-104.
22. Lebrec H., Roger R., Blot C., Burleson G.R., Bohuon C., Pallardy M. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology. 96:1995;147-156.
23. Levene, H., 1960. Robust tests for equality of variances. In: Olkin, I., Ghurye, S.G., Hoeffding, W., Madow, W.G., Mann, H.B. (Eds.), Contributions to Probability and Statistics. Stanford University Press, Stanford, CA, pp. 278-292.
24. Lichtenfels R., Biddison W.E., Schultz H., Vogt A.B., Martin R. CARE-LASS (calcein-release assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods. 172:1994;227-239.
25. Luster M.I., Portier C., Pait D.G., White K.L., Gennings C., Munson A.E., Rosenthal G.J. Risk assessment in toxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:1992;200-210.
26. Maizels N., Lan J.C., Blier P.R., Bothwell A. The T-cell independent antigen, NP-Ficoll, primes for a high affinity IgM anti-NP response. Mol. Immunol. 25(12):1988;1277-1282.
27. Mori H., Sakamoto O., Xu Q., Daikoku M., Koda A. Solid phase enzyme-linked immunosorbent assay (ELISA) for anti-sheep erythrocyte antibody in mouse serum. Int. J. Immunopharm. 11(6):1989;597-606.
28. Morris D.L., Komocsar W.J. Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats. J. Pharmacol. Toxicol. Methods. 37:1997;37-46.
29. National Research Council, 1996. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, Commission on Life Sciences. National Academy Press, Washington, DC.
30. Nygaard U.C., Lovik M. Blood and spleen lymphocytes as targets for immunotoxic effects in the rat - a comparison. Toxicology. 174:2002;153-161.
31. Rehman J., Dillow J., Carter S.M., Chou J., Le B., Maisel A.S. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunol. Lett. 68:1999;391-395.
32. Rittenberg M.B., Pratt K.L. Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc. Soc. Exp. Biol. Med. 132:1969;575-581.
33. Schmid I., Krall W.J., Uittenbogaart C.H., Braun J., Giorgi J.V. Dead cell discrimination in 7-amino-actinomicin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry. 13(2):1992;204-208.
34. Seppala I.J.T., Makela O. Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens. Immunology. 53:1984;827-836.
35. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika. 52(3-4):1965;591-611.
36. Smialowicz R.J., Luebke R.W., Riddle M.M., Rogers R.R., Rowe D.G. Evaluation of the immunotoxic potential of chlordecone with comparison to cyclophosphamide. J. Toxicol. Environ. Health. 15:1985;561-574.
37. Smialowicz R.J., Riddle M.M., Williams W.C. Species and strain comparison of immunosuppression by 2-methoxyethanol and 2-methoxyacetic acid. Int. J. Immunopharmacol. 16(8):1994;695-702.
38. Takahashi Y., Dutta P.R., Cerasoli D.M., Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J. Exp. Med. 187(6):1998;885-895.
39. Temple L., Kawabata T.T., Munson A.E., White K.L. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:1993;412-419.
40. Temple L., Butterworth L., Kawabata T.T., Munson A.E., White K.L. ELISA to measure SRBC specific IgM: method and data evaluation. Methods Immunol. 1:1995;137-157.
41. Vohr, H.W., 1995. Evaluation of toxicity to the immune system. In: Thomas, H., Hess, R., Waechter, F. (Eds.), Toxicology of Industrial Compounds. Taylor & Francis, London, pp. 201-210.
42. Vos J.G., Buys J., Beekof P., Hagenaars A.M. Quantification of total IgM and IgG and specific IgM and IgG to a thymus-dependent (LPS) and a thymus-independent (tetanus toxoid) antigen in the rat by enzyme-linked immunosorbent assay (ELISA). Ann. N. Y. Acad. Sci. 320:1979;518-534.
43. Vos J.G., Van Logton M.J., Kreeftenberg J.G., Kruizinga W. Effect of triphenyltin hydroxide on the immune system of the rat. Toxicology. 29:1984;325-336.
44. White K.L. Validation: state of the art United States National Toxicology Program & Fischer 344 rat cyclosporin a study. J. Toxicol. Clin. Exp. 12(6-7):1992;429-447.
45. Wilson S.D., Munson A.E., Meade B.J. Assessment of the functional integrity of the humoral immune response: the plaque-forming assay and the enzyme-linked immunosorbent assay. Methods. 19(1):1999;3-7.